Atricure, Inc. (ATRC) Tops Q2 EPS by 3c, Boosts FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Piper Jaffray Raises Price Target on Atricure, Inc. (ATRC) to $30 Following 2Q Results
July 29, 2015 10:10 AM EDTPiper Jaffray reiterated an Overweight rating on AtriCure Inc. (NASDAQ: ATRC), and raised the price target to $30.00 (from $23.00), following 2Q15 results. ATRC reported Q2 sales of $32.6M, and EPS of -$0.18, beating out consensus on both metrics. Analyst Thomas Gunderson believes that... More
